Anthony Finbow is the CEO at Eagle Genomics, a pioneer in the application of network science to biology. He has worked for over two decades as a leader, building and scaling deep technology businesses, and has a particular enthusiasm for businesses operating at the intersection of life science and data science. Anthony is currently Vice Chairman of the BIA’s Genomics Advisory Committee. He is also on the Executive Committee of the KTN Microbiome Innovation Network, set up to develop a proactive, self-sustaining microbiome community in the UK and to raise the visibility of the UK’s world leading microbiome science.
As Executive Chairman and CEO, Anthony has built and exited a number of intellectual property-rich B2B software companies. In particular, he was responsible for the turnaround, strategic repositioning and sale of private venture backed communications software company, Psytechnics to US Nasdaq-listed NetScout. Similarly, as Managing Director of MetaSolv, he was responsible for doubling the size of the European business, prior to that company being acquired by Oracle. In his early career, Anthony worked as an aircraft engineer and in industrial lasers and electro-optics. He trained as a lawyer and worked as a banker in the privatization of former East German industrial companies, before moving into leadership roles with technology businesses.